| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/02/2000 | EP1023320A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS |
| 08/02/2000 | EP1023319A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 08/02/2000 | EP1023311A1 Novel bacterial polypeptides and polynucleotides |
| 08/02/2000 | EP1023302A1 Binuclear complex |
| 08/02/2000 | EP1023294A1 Carbapenem derivatives and a preparation method thereof |
| 08/02/2000 | EP1023293A1 Aryloxymethyl carbapenem antibacterials |
| 08/02/2000 | EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 08/02/2000 | EP1023265A1 Azetidinone derivatives for the treatment of hcmv infections |
| 08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
| 08/02/2000 | EP1023062A1 Antibacterial carbapenems, compositions and methods of treatment |
| 08/02/2000 | EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/02/2000 | EP0527889B1 Quinolizinone type compounds |
| 08/02/2000 | CN1261920A Enzymatic DNA molecules |
| 08/02/2000 | CN1261896A Surface antigens and proteins useful in compositions for diagnosis and prevention of lyme disease |
| 08/02/2000 | CN1261895A Cyclic azapeptide with angiogenic effect |
| 08/02/2000 | CN1261889A Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agent |
| 08/02/2000 | CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 08/02/2000 | CN1261810A Method of screening compounds useful for prevention of infection or pathogenicity |
| 08/02/2000 | CN1261806A Polyethylene glycol-interferon alpha conjugates for therapy of infection |
| 08/02/2000 | CN1261797A Self-emulsifying formulation forlipophilic compounds |
| 08/02/2000 | CN1261796A Self-emulsifying formulation for lipophilic compounds |
| 08/02/2000 | CN1261795A Compounds and methods |
| 08/02/2000 | CN1261790A Self-emulsifying formulation for lipophilic compounds |
| 08/02/2000 | CN1055090C Crystilline ceftiofur free acid |
| 08/02/2000 | CN1055024C Actinobacillus pleuropneumoniae subunit vaccine |
| 08/02/2000 | CN1055022C Compound interferon antiviral drug. prepn. and use thereof |
| 08/02/2000 | CN1055016C Powder for removing toxic substances and promoting granulation |
| 08/01/2000 | US6096879 Nucleotide sequence coding microorganismal protein; for the diagnosis of the presence of viral particles in serum |
| 08/01/2000 | US6096869 Treatment of papillomavirus-associated lesions |
| 08/01/2000 | US6096862 Multimeric antiviral agent |
| 08/01/2000 | US6096750 Furopyrimidines and methods of making and using the same derivatives |
| 08/01/2000 | US6096739 Treatment for CNS injuries |
| 08/01/2000 | US6096719 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents |
| 08/01/2000 | US6096714 Erythromycin derivatives, method for preparing same, and use thereof as drugs |
| 08/01/2000 | US6096538 Retroviral vectors |
| 08/01/2000 | US6096535 Feline infectious peritonitis vaccine |
| 08/01/2000 | US6096323 Vaccine against papillomatous digital dermatitis (PDD) |
| 08/01/2000 | US6096322 Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing |
| 08/01/2000 | US6096319 Peptides with amino acid sequences |
| 08/01/2000 | US6096312 Agent for suppressing a reduction of CD4+ lymphocytes |
| 08/01/2000 | US6096300 Suppression of myeloproliferation and anticarcinogenic agents |
| 08/01/2000 | US6096216 Iodinated matrices for disinfecting biological fluids |
| 08/01/2000 | CA2178760C Hiv protease inhibitors |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2127091C Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 08/01/2000 | CA2123786C Method of treating viral infections with c-reactive protein |
| 08/01/2000 | CA2099976C Repressors of the trans-activating function of papillomavirus e2 proteins |
| 08/01/2000 | CA2014771C 5,11-dihydro-6h-dipyrido[3,2-b:2'3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 07/29/2000 | CA2290771A1 Azithromycin combination for emesis control in dogs |
| 07/29/2000 | CA2290078A1 Erysipelothrix rhusiopathiae antigens and vaccine compositions |
| 07/28/2000 | CA2411293A1 Novel azalides and methods of making same |
| 07/28/2000 | CA2293008A1 Premixed alatrofloxacin injectable compositions |
| 07/27/2000 | WO2000043549A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043399A1 3,6-disubstituted penam sulfone derivatives as antibacterials |
| 07/27/2000 | WO2000043394A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
| 07/27/2000 | WO2000043390A1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same |
| 07/27/2000 | WO2000043383A1 Piperidinylquinolines as protein tyrosine kinase inhibitors |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | WO2000043040A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 07/27/2000 | WO2000043037A2 Hiv-encoded chemoattractant |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043026A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 07/27/2000 | WO2000043025A1 Pharmaceutical preparation for treating viral infections |
| 07/27/2000 | WO2000043014A2 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 07/27/2000 | WO2000042994A2 Inhibition of bacterial dissemination |
| 07/27/2000 | WO2000042992A2 Compositions and methods for mucosal delivery |
| 07/27/2000 | WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/27/2000 | WO2000042987A2 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 07/27/2000 | WO2000042864A2 Methods for reducing mortality rates in poultry |
| 07/27/2000 | WO2000042852A1 Compounds and methods |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000025814A3 Component for vaccine against serogroup b meningococci |
| 07/27/2000 | WO2000023592A3 Minimal promoters and uses thereof |
| 07/27/2000 | WO2000023574A3 Hepatitis a vaccines |
| 07/27/2000 | WO2000012684A3 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000003743A9 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 07/27/2000 | WO2000002523A9 Vaccine against staphylococcus intoxication |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | CA2361276A1 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2360803A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2360038A1 Methods for reducing mortality rates in poultry |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | CA2358524A1 Compositions and methods for mucosal delivery |
| 07/27/2000 | CA2355738A1 3,6-disubstituted penam sulfone derivatives as antibacterials |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1022279A1 New carbapenem derivatives |
| 07/26/2000 | EP1022278A1 Tetracyclical derivatives from pyrimidine |
| 07/26/2000 | EP1021555A1 STABILIZATION OF $i(HELICOBACTER) UREASE |
| 07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |